This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Latest Headlines

Multidrug-resistant tuberculosis (MDR-TB) is widespread globally with almost half a million cases documented in 2014. Although rare in European countries, the risks posed by the current migrant crisis makes MDR-TB an important and urgent public health priority. A study just ...More

Childcare personnel properly clean their hands less than a quarter of the times they are supposed to, according to a study published in the December issue of the American Journal of Infection Control. A new study from the University of Arkansas used video cameras to record ...More

Researchers from North Carolina State University have discovered a way to make pinpoint changes to an enzyme-driven "assembly line" that will enable scientists to improve or change the properties of existing antibiotics as well as create designer compounds. The work is the ...More

Use of syringe services programs (SSPs) has increased substantially during the past decade, but most people who inject drugs still don’t always use sterile needles, according to a new CDC Vital Signs report published today. Sharing needles and syringes is a direct ...More

HIV/AIDS remains one of the world's most significant public health challenges, particularly in low- and middle-income countries. The World Health Organization (WHO) offers the following 10 facts on HIV/AIDS. ...More

Physicians at five U.S. medical centers are planning to enroll up to 400 children in a clinical trial to evaluate whether a shorter course of antibiotics — five days instead of 10 — is effective at treating community-acquired pneumonia (CAP) in children who show ...More

The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults. The study, called HVTN 702, involves a new version of the only HIV vaccine candidate ever ...More

In advance of World AIDS Day, Dec. 1, 2016, the World Health Organization (WHO) has released new guidelines on HIV self-testing to improve access to and uptake of HIV diagnosis. According to a new WHO progress report, lack of an HIV diagnosis is a major obstacle to ...More

With 29,747 newly reported HIV infections in 2015, the EU/EEA notification rate is similar to recent years with an overall insignificant change from 6.6 per 100,000 population in 2006 to 6.3 in 2015 (adjusted for reporting delay). ...More

Myocarditis, an assortment of heart disorders often caused by infection and inflammation, is known to be difficult to diagnose and treat. But the picture of who is affected is becoming a little clearer. Men may be as much as twice as likely as women to develop severe and ...More